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The P2X7 receptor (P2X7R) is an ATP-gated ion channel known for its proinflammatory
activity. Despite its participation in host defense against pathogens, the role played in viral
infections, notably those caused by herpes viruses, has been seldom studied. Here we
investigated the effect of P2X7R expression on human herpes virus 6 A (HHV-6A) infection
of P2X7R-expressing HEK293 cells. We show that functional P2X7R increases while its
blockade decreases viral load. Interestingly, HHV-6A infection was enhanced in HEK293
cells transfected with P2X7R cDNA bearing the gain of function 489C>T SNP (rs208294,
replacing a histidine for tyrosine at position 155). The P2X7R 489C>T polymorphism
correlated with HHV-6A infection also in a cohort of 50 women affected with idiopathic
infertility, a condition previously shown to correlate with HHV-6A infection. None of the
infertile women infected by HHV-6A was homozygote for 489CC genotype, while on the
contrary HHV-6A infection significantly associated with the presence of the rs208294
allele. Levels of soluble human leukocyte antigen G (sHLA-G), a factor promoting embryo
implant, measured in uterine flushings negatively correlated with the 489TT genotype and
HHV-6A infection, while proinflammatory cytokines interleukins 1a (IL-1a), 1b (IL-1b), and
8 (IL-8) positively correlated with both the 489T allele presence and viral infection. Taken
together these data point to the P2X7R as a new therapeutic target to prevent HHV-6A
infection and the associated infertility.
Keywords: P2X7, P2X7 489C>T polymorphism, HHV-6A infection, female infertility, HLA-GINTRODUCTION
The P2X7 receptor (P2X7R) ATP receptor is an ion channel belonging to the family of P2X
receptors. The functional P2X7R is formed by a homomeric trimer whose subunit consists of a large
extracellular loop including the agonist and antagonist binding sites, two alpha-helical
transmembrane regions, and intracellular N and C-terminal peptides. Due to its widespreadin.org February 2020 | Volume 11 | Article 961
Pegoraro et al. P2X7 and HHV-6A Infectionexpression on immune cells and its ability to release cytokines
the best-recognized function of P2X7R is to participate
in inflammato ry r e a c t i on s . In the infl ammato ry
microenvironment, ATP is released from dying cells as a
damage-associated molecular pattern (DAMP) to activate the
P2X7R and the following NLRP3-dependent release of several
proinflammatory cytokines including interleukin (IL)-1b, IL-1a,
and IL-18 (Di Virgilio et al., 2017; Orioli et al., 2017; Adinolfi
et al., 2018). Accordingly, P2X7R can down-modulate the
activity of anti-inflammatory molecules such as human
leukocyte antigen (HLA)-G (Rizzo et al., 2009), an HLA class
Ib molecule implicated in embryo protection and implantation
via immune cells inhibition (Rizzo et al., 2007b). Moreover,
P2X7R promotes hypoxia-inducible factor 1-a (HIF-1a)
activation, vascular endothelial growth factor (VEGF)
secretion, and neovascularization (Hill et al., 2010; Adinolfi
et al., 2012; Amoroso et al., 2012; Amoroso et al., 2015). The
human P2X7R is a highly polymorphic gene harboring over
13.000 single nucleotide polymorphisms (SNPs) the majority of
which are nonsynonymous, intronic, or missense (Benzaquen
et al., 2019). However, a small number of these SNPs has been
shown to change receptor function, either as loss- (10) or gain-
(3) of-function variants (Stokes et al., 2010; Bradley et al., 2011;
De Marchi et al., 2016; Sluyter, 2017). Such diversity has been
attributed to environmental pressure by infectious agents, such
as mycobacterium tuberculosis, and association with chronic
inflammatory diseases (Adinolfi et al., 2018). The most frequent
human P2X7R SNP is 489C>T (rs208294, 47% frequency),
leading the substitution of histidine 155, localized in the
P2X7R ectodomain, with a tyrosine (H155Y) (Cabrini et al.,
2005). Intriguingly, the CC genotype seems to be present mainly
in the human receptor while the TT genotype, is the prevailing
variant of the receptor in both mouse and rat (North and
Surprenant , 2000) . The 489C>T gain of funct ion
polymorphism has been recently associated with Alzheimer’s
disease pathogenesis (Sanz et al., 2014) and in the accelerated
release of proinflammatory cytokines observed in Lupus
complicated with pericarditis (Hu et al., 2019). However, its
implication in human disorders etiology remains understudied.
The P2X7R plays a major role in the response to infectious
diseases, in particular, those caused by intracellular pathogens,
via either direct effect on pathogen cell entry and survival or
modulation of innate and adaptive immune responses (Adinolfi
et al., 2018; Savio et al., 2018; Savio and Coutinho-Silva, 2019). In
this context, the effect of P2X7R activation is not always
beneficial or detrimental but depends upon the specific
pathogen, its virulence and the severity of the infection (Savio
et al., 2018). Therefore, the P2X7R can act as both host-
protecting and infection-promoting factor. In viral infections,
P2X7R inhibition protects against hepatitis, influenza,
adenoviruses and HIV but it is detrimental in the case of
vesicular stomatitis and Dengue viruses (Adinolfi et al., 2018;
Savio et al., 2018). As per herpes viruses infections, limited
evidence is available, showing P2X7R upregulation following
cytomegalovirus infection (Zandberg et al., 2007). Human herpes
virus 6 (HHV-6), a member of the Betaherpesvirinae subfamilyFrontiers in Pharmacology | www.frontiersin.org 2and the causative agent of roseola infantum, has a wide cell
tropism, albeit T cells are a preferred target. The acronym HHV-
6 includes two distinct viruses, HHV-6A and -6B. HHV-6A
recently emerged as a possible determinant of female idiopathic
infertility, because infection by this virus alters endometrial
immune cell responses and cytokine composition of the
uterine milieu (Marci et al., 2016; Caselli et al., 2017; Bortolotti
et al., 2019). Furthermore, HHV-6A infection causes a reduction
in protein levels of the widely used phenotypic decidualization
markers HLA-G (Rizzo et al., 2011) and mucin1 (MUC1)
(McAuley et al., 2017). In this study, we explored the role
played by the P2X7R in favoring HHV-6A infection and the
associated infertility.MATERIALS AND METHODS
Cell Lines and Cultures
The acronyms HEK CC, HEK TT, and HEK mock are referring
to HEK293 cells stably expressing human P2X7R-489CC, human
P2X7R-489TT, and the empty expression vector PcDNA3, which
were obtained as described in (Adinolfi et al., 2005; Cabrini et al.,
2005). HEK293 cells were cultured in DMEM high glucose
(Sigma), complemented with 10% heat-inactivated fetal bovine
serum (FBS) (Euroclone, Milan, Italy), 100 U/ml penicillin
(Euroclone), 100 mg/ml streptomycin (Euroclone), 1% non-
essential amino acids (Sigma), and G418 sulfate 0,4 mg/ml
(Sigma). HEC-1A endometrial epithelial cancer cell line
(ATCC HTB-112) was cultured in McCoy’s 5a Medium (Sigma).
P2X7R Immunofluorescence
Recep tor ’ s su r f a c e expre s s i on was confi rmed by
immunocytochemistry (see Supplementary Figure 1). HEK
mock, HEK CC and HEK TT cells were seeded on coverslips
fixed with 4% paraformaldehyde for 15 min at 37°C, rinsed three
times with phosphate-buffered saline (PBS), incubated in
blocking buffer [PBS with 1% bovine serum albumin (BSA)]
for 45 min at room temperature. Coverslips were then incubated
with the antihuman P2X7R monoclonal antibody (mAb),
previously characterized by Buell et al. (1998) kindly provided
by Professor James Wiley (Florey Neuroscience Institutes,
University of Melbourne, Australia) overnight at 4°C at a
dilution of 1:50. Samples were rinsed and incubated with a
TRICT conjugated anti-mouse antibody (T5393, Sigma-
Aldrich) at a dilution of 1:500 for 1 h at room temperature.
Fluorescence was visualized with a Leica DMI 4000B microscope
equipped with 100× oil objective and images were acquired
thanks to a Leica DFC 550 camera.
HHV-6A Cell Infection and Assays for
HHV-6 Detection
HEK293 and HEC-1A cells were infected with HHV-6A (strain
U1102) cell-free virus inocula (Caselli et al., 2017) at a
multiplicity of infection of 100 genome equivalents per 1 cell
for 2 h at 37°C. HHV-6A antigen expression was analyzed by
immunofluorescence 5 days post-infection (dpi) with a mouseFebruary 2020 | Volume 11 | Article 96
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HHV-6A (ABI, Columbia, MD, United States), as previously
described (Caselli et al., 2017).
HHV-6A DNA extraction and analysis was performed as
previously described (Rizzo et al., 2019). Briefly, real-time
quantitative polymerase chain reaction (qPCR) specific for the
U94 gene was used to determine HHV-6A DNA presence and
load. Positive samples were considered those in which 1 µg of
cellular DNA harbored more than 100 copies of viral DNA. The
following set of primers/probe was used for qPCR: HHV6 U94
(+) (5′-GAG CGC CCG ATA TTA AAT GGA T-3′); HHV6 U94
(−) (5′-GCT TGA GCG TAC CAC TTT GCA-3′); HHV6 U94
PROBE (5′-FAM-CTG GAA TAA TAA AAC TGC CGT CCC
CAC C-TAMRA-3′). The standard curve was generated by
amplification of a plasmid containing the targeted HHV-6
sequences. Human RNase P or beta-actin housekeeping genes
were used as a control.
RNA cell extraction was performed with the RNeasy kit
(Qiagen, Hilden, Germany). The absence of contaminant DNA
in the extracted RNA was assured by DNase treatment and
control b-actin PCR without retrotranscription reverse
transcription (Caselli et al., 2017; Rizzo et al., 2017). The
analysis of virus transcripts was performed by RNA reverse
transcription with the RT2 First-strand kit (Qiagen, Hilden,
Germany) using cDNA aliquots obtained from 200 ng RNA
(Menegazzi et al., 1999; Caselli et al., 2012). The specific primers
used to amplify HHV-6A U42 were: forward 3′ACGATGGA
CATGGCTTGTTG5′; reverse 3′ACCTTACAACGGAGAC
GCC5′ (Caselli et al., 2012). The methods had a 6-log dynamic
range and a sensitivity of 20 copies/ml. Each sample was run
in duplicate.
HLA-G Detection
Ten microliters of cell culture supernatants or uterine flushing
samples were assayed for soluble HLA-G using a bead array Bio-
Plex system (BioRad, CA, USA) with anti-HLA-G MoAb (G233;
Exbio, Czech Republic) conjugated beads, as previously reported
(Rizzo et al., 2007a).
CD46 Flow Cytometry
CD46 surface expression data were analyzed using FACS CantoII
flow cytometer (BD, Milan, Italy) and FlowJo LLC analysis
software (Ashland, Oregon, USA). Cells (1 ×105) were labeled
with CD46-PE (R&D Systems, Italy) or matched isotype
controls. Ten thousand events per cell type were acquired.
Clinical Samples
Endometrial specimens were obtained by biopsy from patients
admitted for tubal patency assessment by Hystero-sono contrast
sonography at secretory stage of the menstrual cycle. The
endometrium was prepared as previously described (Marci
et al., 2016). Endometrial epithelial cells were collected from
the Ficoll-Paque-medium interface using BerEP4-coated
magnetic Dynabeads system (Dynal Biotech, Oslo, Norway).
The sorted epithelial cells were typed for HHV-6A or B
identification. DNA extraction and analysis were performed as
previously described (Caselli et al., 2012). Above-mentionedFrontiers in Pharmacology | www.frontiersin.org 3qPCR was used to determine HHV-6 DNA presence and load.
All samples were randomly and blindly investigated and we
obtained enough material the analysis was repeated twice in a
randomized and blinded fashion at a distant time set from the
first determination. HHV-6A or B identification was performed
as reported previously (Caselli et al., 2012), by restriction enzyme
digestion of the U31 nested PCR amplification product and
visualization of the digestion products on ethidium bromide-
stained agarose gel after electrophoresis migration.
Uterine flushing samples were obtained from the same
patients including only 21–38 years old women, with regular
menstrual cycle (24–35 days), a body mass index (BMI) ranging
between 18 and 26 kg/m2, follicle-stimulating hormone (FSH;
days 2–3 of the menstrual cycle) < 10 mUI/ml, 17-b-estradiol <
50 pg/ml (days 2–3 of the menstrual cycle), normal karyotype.
Women that presented endometritis, endometriosis, tubal factor,
ovulatory dysfunction, anatomical uterine pathologies, and
recurrent miscarriage were excluded. Uterine flushing was
performed with a 14-gauge Foley three-way balloon catheter
(Eschmann) inflating an appropriate (5 ml) amount of sterile
physiologic saline solution (Rizzo et al., 2017). Genomic DNA
for P2X7R polymorphism assessment and circulating HHV6-A
and B detection was isolated from whole blood using the
QIAamp DNA Blood Mini kit (QIAGEN, Hilden, Germany).
This study was approved by the “University-Hospital of Ferrara
Ethics Committee.” All subjects gave written informed consent
in accordance with the Declaration of Helsinki.
P2X7R 489C>T Polymorphism Analysis
The presence of 489C>T SNP was determined by real-time PCR
using an allelic discrimination TaqMan MGB probe technique
with a Step One Real-Time PCR thermal cycler (Applied
Biosystem) as previously described (Cabrini et al., 2005).
Briefly, genomic DNA (100 ng) was added to the PCR master
mix (TaqMan Universal PCR Master Mix, Applied Biosystems)
in the presence of validated primers and probes (Applied
Biosystems, ID number: C:_3019032_1_). Following 40 PCR
cycles (15 s at 95°C for denaturation and 1 min at 60°C
annealing plus elongation), genotype was assigned to each
sample analyzing the fluorescent signal.
Cytokines and Growth Factor Evaluation in
Uterine Flushing Samples
Cytokines were analyzed in uterine flushing samples using
Cyraplex assay (Aushon, distributed by Tema Ricerca, Bologna,
Italy) according to the manufacturers’ instructions. VEGF levels
were assessed by PicoKine™ ELISA kit (Boster, distributed by
Tema Ricerca, Bologna, Italy).
Measurement of Cytosolic Ca2+
Changes in the intracellular HEC-1A Ca2+ concentration were
measured wi th the fluorescen t ind i ca tor Fura -2 /
acetoxymethylester (Fura-2/AM), using a Cary Eclipse
Fluorescence Spectrophotometer (Agilent Technologies, Milan,
Italy). Cells were seeded on a coverslip and maintained at 37°C in
a 5% CO2 humidified incubator until confluence. The confluent
monolayers were loaded with Fura-2/AM (4 mM) in standardFebruary 2020 | Volume 11 | Article 96
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NaH2PO4, 20 mM HEPES, 5.5 mM glucose, 5 mM NaHCO3, 1
mM CaCl2, and 250 mM sulfinpyrazone (Sigma-Aldrich).
Incubation was performed at 37°C for 20 min. Cells were then
washed and changes of intracellular [Ca2+] were determined after
stimulation with 300 mM 2′-(3′)-0-(4-benzoylbenzoyl) ATP
(Sigma-Aldrich) following, whenever required, by 10-min
incubation with AZ10606120, in a thermostated cuvette under
stirring, with a 340/380 excitation ratio at an emission
wavelength of 505 nm.
Statistics and Data Availability
Data were analyzed for normality by Kolmogorov–Smirnov test.
All the variables resulted normally distributed. Therefore,
analysis of variance (ANOVA) and two-tailed Student’s t tests
were used to compare most of the variables. X2 test and Fisher
exact test were used to compare allelic and genotypic frequencies
and positivity for HHV6-A (Table 1) and sHLA-G (Figure 2B)
respectively. P-values lower than 0.05 were considered
statistically significant. All statistic evaluations were performed
thanks to GraphPad Prism software (GraphPad, La Jolla,
California, USA). The raw data supporting the conclusions of
this manuscript will be made available by the authors, upon
reasonable request, to any qualified researcher.RESULTS
P2X7R Favors HHV-6A Infection in
HEK293 Cells
HEK293 human embryonic kidney cells are an interesting model
for P2X scholars as they do not express a functional P2X7R
receptor or any other member of the P2X family and can be
easily transfected to induce the overexpression of virtually all
P2X receptors (Adinolfi et al., 2005). Therefore we used HEK293
stably transfected cell clones carrying either a) the WT P2X7R
SNP, i.e. the 489CC genotype (HEK CC), or b) the gain of
function P2X7R SNP, i.e. the 489TT genotype (HEK TT) or the
empty vector (HEK mock) and challenged them with HHV-6A
virions. Figure 1 shows that P2X7R expression strongly increases
HHV-6A infection in HEK293 cells. The viral infection is
dependent upon the 489 P2X7R genotype as HEK TT are
infected in a significantly higher percentage if compared to
HEK CC (Figures 1A, B, F). Moreover, both late gene U94
DNA and immediate early U42 gene RNA levels are 1 log higher
in HEK TT in comparison with HEK CC and the expression of
both receptors variants leads to an increase of about 2 logs of
HHV6-A genes as compared to HEK mock cells (Figures 1G,
H). P2X7R antagonism with AZ10606120 strongly reduced
HHV-6A infection in HEK TT cells as demonstrated by both
immunofluorescence (Figures 1B, E, F) and gene evaluation data
(Figures 1G, H). However, HEK CC HHV-6A positivity was
only slightly reduced by the receptor antagonist (Figures 1G, H)
and viral DNA and RNA expression, although presenting a clear
trend toward reduction (~20%) were not significantly affected
(Figures 1G, H). Since HHV-6A entry into target cells isFrontiers in Pharmacology | www.frontiersin.org 4determined by CD46 surface expression (Santoro et al., 1999),
we evaluated CD46 levels on the surface of HEK293 transfected
with the different P2X7R variants (Figure 1I). However, P2X7R
expression or genotype did not affect the expression of the HHV-
6A receptor CD46 (Figure 1I) (p = 0.34; ANOVA test),
supporting a role for P2X7R in the control of viral infection.
Since we know that both P2X7R and HHV-6 can affect HLA-G
expression (Rizzo et al., 2009; Caselli et al., 2015), we measured
HLA-G concentration in HEK293 culture supernatants (Figure
1J). Secretion of HLA-G was different between the different
samples (p = 0.0012; ANOVA test). Soluble HLA-G (sHLA-G)
inversely correlated with P2X7R expression and was dependent
upon 489 SNP with the 489TT genotype associated with a larger
reduction of HLA-G release (p < 0.001; Student t-test)
(Figure 1J).P2X7R 489CC Protects Against HHV-6A
Infection and Affects the Uterine Cytokine
Milieu in Infertile Women
We next investigated the association of P2X7R 489C>T SNP with
HHV-6A infection in a pathological condition. HHV-6A
infection and low HLA-G levels in the uterine environment
were recently associated with female idiopathic infertility (Marci
et al., 2016; Bortolotti et al., 2019), therefore we analyzed the
frequency of 489C>T SNP and the presence of HHV-6A DNA in
endometrial biopsies from a cohort of 50 women with idiopathic
infertility. The endometrial biopsies were analyzed for the
presence of HHV-6A and B infection. More than 20% (11/50)
women with idiopathic infertility were positive for HHV-6A
DNA in their endometrial epithelial cells. HHV-6B DNAwas not
present in all the endometrial biopsies as previously reported
(Marci et al., 2016; Bortolotti et al., 2019). The average viral load
in endometrial epithelial cells from HHV-6A positive infertile
women was 490.000 copies/µg of cellular DNA (range 698.000–
236.000 copies/µg DNA), corresponding to about 4 copies of
viral DNA per diploid cell. As a control, we evaluated HHV-6A
and HHV-6B DNA presence in the peripheral blood
mononuclear cells (PBMCs) of our population. While we
confirmed the previously reported 25% positivity for HHV-6B
virus (Caselli, 2007) HHV6-A was not present in PBMCs from
our population (not shown). Table 1 shows a negative
associat ion between HHV-6A infection and 489 C
homozygosis with the number of infected women significantly
growing with the presence of the minor gain of function allele
489T. These data strongly suggest an association between the
rs208294 allele and the susceptibility to HHV6-A infection in
idiopathic infertile women. Analysis of HLA-G concentration in
uterine flushings from the same women revealed a clear tendency
toward a decrease of HLA-G from HHV-6A negative/489CC to
HHV-6A positive/489TT subjects (Figure 2A). The high
variability in HLA-G concentration found in our population
was due to the presence of flushing samples where HLA-G was
either absent or below the threshold for detection. Therefore, we
re-analyzed the population comparing the percentage of HLA-G
positive versus HLA-G negative flushing samples by fisher exact
test (Figure 2B). This analysis highlighted statistically significantFebruary 2020 | Volume 11 | Article 96
Pegoraro et al. P2X7 and HHV-6A InfectionFIGURE 1 | (A–H) HHV6-A infection of HEK293 cells. Cells were infected with 100 genome equivalents per cell of HHV-6A for 2 h at 37°C in the presence or not of
P2X7R antagonist AZ10606120 (2 µM). (A–E) Fluorescence pictures of HHV-6A infected HEK CC (A, D), HEK TT (B, E), and HEK mock cells (C) stained with anti-
gp116 mAb. (F) Percentage of HEK CC and HEK TT cells positive for HHV-6A gp116 protein in the presence or not of P2X7R antagonist AZ10606120. HHV-6A
positivity significantly differs among groups [p < 0.0001, analysis of variance (ANOVA) test]. Data for each group are shown as the mean ± SEM of four experiments.
Groups were compared with each other using two-tailed Student’s t-test, *p < 0.05, ***p < 0.001. HHV6-A U94 DNA (G) and U42 RNA levels (H). U94 DNA and
U42 RNA were quantified by polymerase chain reaction (PCR) and quantitative PCR (qPCR) as reported in Materials and Methods. (I) Mean fluorescence intensity
(MFI) of HHV-6A membrane receptor CD46 on HEK mock, HEK CC, and HEK TT cells. Expression of CD46 is not significantly different among groups (p = 0.34,
ANOVA test). (J) Human leukocyte antigen G (HLA-G) concentration was evaluated in HEK mock, HEK CC, and HEK TT cell culture supernatants and differed
among the samples (p = 0.0012; ANOVA test). Data for each group are shown as the mean ± SEM of four experiments. Groups were further compared with each
other using two-tailed Student’s t-test, *p < 0.05, ***p < 0.001.Frontiers in Pharmacology | www.frontiersin.org February 2020 | Volume 11 | Article 965
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genotype and HHV-6A status of infection, with the HHV-6A
negative/489CC subjects showing the highest HLA-G
percentages as compared to infected and 489TT women
(Figure 2B). On the contrary, proinflammatory cytokines and
chemokines showed a tendency to increase in the presence of
489T allele and HHV-6A infection (Figures 2C–E). As expected,
based on the central role played by P2X7R in its maturation and
secretion, IL-1b flushing concentrations differed between the
cohorts (p = 0.0132; ANOVA test), tending to increase in women
with the 489T allele, reaching statistically significantly high
concentrations in subjects both homozygous for 489T and
infected with HHV-6A (p < 0.001; Student t-test) (Figure 2C).
A similar trend was also observed for IL-1a (p = 0.03; ANOVA
test) (Figure 2D) and IL-8 (p = 0.045; ANOVA test) (Figure 2E).
Finally VEGF concentration in the flushing samples solely
associated with 489TT genotype independently of the infection
status (p = 0.012; ANOVA test) (Figure 2F). Other cytokines
tested, including IFNg, IL-4, IL-6, IL-10, IL-12p70, and TNF-a,
were either undetectable or present at low concentrations and
did not significantly differ within the tested populations
(Supplementary Figure 2). As a proof of concept of the
expression of P2X7R by endometrial epithelial cells, we
analyzed HEC-1A endometrial epithelial cell line. Interestingly,
a functional P2X7R, homozygous for the 489T allele, was also
found in these cells (Figure 3A). We observed significant
infection of these cells that was reduced by P2X7R antagonism
with AZ10606120 (Figure 3B).DISCUSSION
Purinergic signaling is known to participate in viral infection and
replication, and in anti-viral inflammatory responses and,
consequently, purinergic receptors have been proposed asFrontiers in Pharmacology | www.frontiersin.org 6targets for antiviral therapy (Ferrari et al., 2018; Savio et al.,
2018; Zhang et al., 2019). Among P2 purinergic receptors, the
P2X7R is one of the best candidates for such intervention as its
activity in promoting or inhibiting viral infection, or alternatively
its ability to support antiviral responses was widely
demonstrated. Furthermore, several potent and selective
inhibitors have been developed over time (De Marchi et al.,
2016; Di Virgilio et al., 2017; Adinolfi et al., 2018; Savio et al.,
2018). In the present study, we showed a predisposing role for
the P2X7R in mediating HHV-6A infection. This activity was not
due to changes in the expression of the known viral receptor
CD46 since its levels remained unaltered in P2X7R expressing
cells as compared to mock control. In support of a main role of a
functional P2X7R, we also showed that a selective P2X7R
blocker, AZ10606120 (De Marchi et al., 2019), reduced HHV-
6A infection especially in HEK TT P2X7R-expressing cells.
The identification of new drugs that can counteract HHV-6
infection is of extreme importance. Increased awareness of
diseases associated with HHV-6 acute infection, in both
immunocompetent and immunocompromised patients, has
spurred interest in the development of effective treatments for
HHV-6-mediated diseases. A number of drugs used for
cytomegalovirus infection have shown in vitro efficacy against
HHV-6. Dozens of case reports and several small clinical studies
have demonstrated the efficacy of different compounds against
HHV-6 infection. However, no drug has yet been approved for
use in humans. The discovery that P2X7R expression facilitates
HHV-6A infection opens an entirely novel avenue for anti-viral
drug therapy. Our data show that HHV-6A infection in vitro and
in vivo depends on P2X7R function as it is enhanced in the
presence of the gain of function 489TT polymorphic variant.
Previous studies showed that this polymorphism increases
P2X7R activity as both a small ion channel and large cation
permeation pathway (Cabrini et al., 2005; Roger et al., 2010) and
that this phenotype is possibly linked to increased cell surface
expression of P2X7R (Bradley et al., 2011). These data suggest
that the SNP could favor viral entry either due to P2X7R
membrane pore formation or to viral direct interaction on the
cell surface. Another possible explanation for P2X7R-mediated
HHV6-A cellular entry could be receptor-dependent phagocytic
uptake (Gu and Wiley, 2018; Ou et al., 2018). Moreover, P2X7R-
dependent increased HHV-6A infection inversely correlated
with the secretion of HLA-G from HEK293 cells thus
suggesting also an effect on the activation of the immune
system (Eliassen et al., 2017). Data from HEK293 cells were
confirmed by the complete absence of the 489CC homozygous
genotype in primary infertile women bearing an endometrial
HHV-6A infection (Table 1). To further support the role of the T
allele in promoting HHV-6A infection, infection rates increase in
parallel with 489T allele (Table 1). In agreement with the
findings in HEK293 cells, also in the patient cohort the 489TT
genotype correlated with decreased presence of sHLA-G in
uterine flushing samples (Figures 2A, B). This observation is
in keeping with the known modulatory effect of HHV-6A
infection on HLA-G expression (Rizzo et al., 2018). HHV-6-
induced increase of HLA-G is likely mediated by humanTABLE 1 | Allele and genotype frequencies of P2X7R polymorphism 489C>T in
infertile women population (n = 50) subdivided according to HHV-6A infection
into HHV-6A negative women (HHV-6A−, n = 39) and HHV-6A positive women
(HHV-6A+, n = 11).
Polymorphism 489C>T Allele frequency % Genotype frequency %
C T CC CT TT
Infertile women* (n = 50) 0.58 0.42 32 52 16
HHV-6A infection
HHV-6A -$ (n = 39) 0.65 0.35 41 49 10
HHV-6A +*$ (n = 11) 0.32 0.68 0 63 37*p = 0.0358 HHV-6A+ women vs overall population (X2 test).
$p = 0.0021 HHV-6A - women vs HHV-6A+ women (X2 test).
The genotype frequencies of HHV-6A− and HHV-6A+ women were compared between
them and with those of the total tested population. The genotype frequencies were found
significantly different in HHV-6A+ women as compared to the overall population (p =
0.0358) and HHV-6A−women (p = 0.0021). While, no significant difference between HHV-
6A− women and the overall population was found (p = 0.3911). P-value was calculated
with the X2 test. HHV-6A negative with P2X7R 489 genotype CC (n = 16), HHV-6A
negative with P2X7R 489 genotype CT (n = 19), HHV-6A negative with P2X7R 489
genotype TT (n = 4), HHV-6A positive with P2X7R 489 genotype CT (n = 7), HHV-6A
positive with P2X7R 489 genotype TT (n = 4).February 2020 | Volume 11 | Article 96
Pegoraro et al. P2X7 and HHV-6A Infectiontranscription factor ATF3, that binds a consensus sequence on
the HLA-G promoter (Rizzo et al., 2018). The largest difference
in cytokines, chemokines and growth factors in uterine flushings
was measured between the 489 CC/HHV-6A negative and the
489TT/HHV-6A positive subjects. 489TT/HHV-6A positive
women also showed higher levels of IL-1b, IL-1a, and IL-8
(CXCL8) suggesting that the 489TT gain-of-function variant not
only favors virus entry but also triggers a wide inflammatory
response that might contribute to female infertility (Tsimis et al.,
2017). It is therefore tempting to speculate that P2X7R-mediatedFrontiers in Pharmacology | www.frontiersin.org 7HHV-6A infection and the associated female-infertility might
have been a drive for negative selection of the 489T variant in
favor of the 489C variant, and a possible mechanism that has
favored this hypomorphic allele in humans as opposed to
rodents, which are not infected by HHV-6 (Reynaud and
Horvat, 2013) and where the 489T is the common allele
(Surprenant et al., 1996; Rassendren et al., 1997; Chessell et al.,
1998). Our data also confirm that the 489T allele increases
P2X7R channel and pore function (Cabrini et al., 2005; Roger
et al., 2010) as well as IL-1, IL-8, and VEGF secretionFIGURE 2 | Correlation between P2X7R polymorphism 489C>T and uterine milieu composition of infertile women infected or not with HHV-6A virus. (A–F) HLA-G,
interleukin (IL)-1b, IL-1a, IL-8, and vascular endothelial growth factor (VEGF) concentrations were evaluated in uterine flushing samples from infertile women (n = 50)
and analyzed according to P2X7R 489 genotype and HHV-6A infection as follows: HHV-6A negative with P2X7R 489 genotype CC (n = 16), HHV-6A negative with
P2X7R 489 genotype CT (n = 19), HHV-6A negative with P2X7R 489 genotype TT (n = 4), HHV-6A positive with P2X7R 489 genotype CT (n = 7), and HHV-6A
positive with P2X7R 489 genotype TT (n = 4). (A) HLA-G concentrations are not significantly different among the groups analyzed (p = 0.3196, ANOVA test).
However, when analyzing the percentage of samples positive for HLA-G (B) according to P2X7R 489C>T polymorphism and HHV-6A infection there is a significant
decrease of positivity of HLA-G in women positive for the virus and carrying 489T allele (B) (p < 0.05, Fisher’s exact test). (C–F) Proinflammatory cytokines and
VEGF concentrations are affected by P2X7R genotype and HHV-6A positivity. IL-1b (C), IL-1a (D), IL-8 (E), and VEGF (F) concentrations are different among the
samples by ANOVA test (p = 0.0132, p = 0.03, p = 0.045, p = 0.012, respectively). Data for each group are shown as the mean ± SEM and compared with each
other using two-tailed Student’s t-test, *p < 0.05, **p < 0.01, and ***p < 0.001.February 2020 | Volume 11 | Article 96
Pegoraro et al. P2X7 and HHV-6A Infection(Orioli et al., 2017). P2X7R-mediated modulation of the uterine
microenvironment could be due to both immune and
endometrial cells, as these latter do express a functional
P2X7R. Interestingly, P2X7R antagonism strongly reduced
HHV6-A infection rate in HEC-1A endometrial cells
(Figure 3) opening the way to the application of P2X7R
targeting drugs also to this cellular subset.
Our data suggest a possible therapeutic application of P2X7R
antagonists in young idiopathic infertile women. P2X7R blockers
could be ideally locally administered in the endometrium to
prevent or lower HHV-6A infection. Additionally, P2X7R
blockade during the implantation window should help to
reconstitute endometrial receptivity on one hand via induction
of HLA-G and on the other via reduction of proinflammatory
cytokines, chemokines, and VEGF. The recent use of P2X7R
antagonists in several clinical trials guarantees their safety and a
quick transfer to the clinical practice (De Marchi et al., 2016; Di
Virgilio et al., 2017; Park and Kim, 2017; Di Virgilio et al., 2018),
making them in principle useful therapeutic tools also in otherFrontiers in Pharmacology | www.frontiersin.org 8HHV-6A-associated diseases such as roseola infantum,
autoimmune diseases, chronic fatigue syndrome, encephalitis,
and Alzheimer’s disease (Rizzo et al., 2019).DATA AVAILABILITY STATEMENT
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